BioCatalyst

GRT-C901, GRT-R902, Atezolizumab, Ipilimumab — catalyst calendar

1 verified catalyst event(s) referencing GRT-C901, GRT-R902, Atezolizumab, Ipilimumab, each linked to its official source. Verified as of 2026-10-31.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Chec
Phase 2/3 · Colorectal Neoplasms
 Seattle Project Corporation GRT-C901, GRT-R902, Atezolizumab, Ipilim ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.